Wird geladen...
NEXT GENERATION ORAL PrEP: BEYOND TENOFOVIR
PURPOSE: Clinical trials of oral pre-exposure prophylaxis (PrEP) have focused testing on regimens of tenofovir (TDF) with or without emtricitabine (FTC). However, TDF may be associated with toxicities (renal, bone) and FTC may select for drug resistance. In this review, we discuss agents that might...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732461/ https://ncbi.nlm.nih.gov/pubmed/23032733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0b013e328358b9ce |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|